Seroba is a life sciences venture capital firm that focuses on investing in healthcare technologies.
Business Model:
Revenue: $4.8M
Employees: 11-50
Address: 18 Herbert Street
City: Dublin
State: county dublin
Zip:
Country: IE
Seroba is a life sciences venture capital firm that focuses on investing in healthcare technologies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2021 | Palliare | Series A | 0 |
6/2005 | Diabetica | Series A | 1.2M |
1/2014 | Apica Cardiovascular | Venture Round | 1.5M |
7/2021 | Coave Therapeutics | Series B | 0 |
11/2009 | Quanta | Series A | 14.3M |
6/2020 | Shorla Pharma | Series A | 8.3M |
4/2023 | Complement Therapeutics | Series A | 0 |
2/2017 | Prexton Therapeutics | Series B | 31.1M |
2/2005 | Opsona | Series A | 6.6M |
2/2009 | Opsona | Series B | 22.8M |
3/2017 | Medlumics | Series B | 36.9M |
5/2011 | Novate Medical | Series B | 12.4M |
2/2022 | Perfuze | Series A | 0 |
12/2011 | Biosensia | Venture Round | 1.6M |
1/2019 | PQ Bypass | Private Equity Round | 0 |
12/2010 | Provesica | Venture Round | 6.2M |
6/2005 | TriMed Research | Venture Round | 6.1M |
4/2019 | Fusion Pharmaceuticals | Series B | 0 |
3/2021 | INNOVO by Atlantic Therapeutics | Venture Round | - |
1/2019 | INNOVO by Atlantic Therapeutics | Series B | 32.1M |
4/2014 | Heart Metabolics | Series A | 20M |
2/2008 | Biosensia | Venture Round | 0 |
12/2022 | Storm Therapeutics | Series B | 30M |
5/2019 | Storm Therapeutics | Series A | 17.8M |
6/2021 | Quanta | Series D | 0 |
1/2015 | Veryan Medical | Series B | 0 |
3/2017 | INNOVO by Atlantic Therapeutics | Series A | 15.8M |
10/2022 | Sibylla Biotech | Series A | 0 |
1/2023 | Deciphex | Series B | 4.2M |
7/2019 | Quanta | Series C | 0 |
4/2010 | Veryan Medical | Series A | 5.4M |
6/2009 | Opsona | Series B | 4.6M |
10/2011 | Veryan Medical | Venture Round | 8.1M |
9/2017 | Fusion Pharmaceuticals | Series A | 0 |
11/2010 | Covagen | Series A | 6.3M |
12/2013 | Covagen | Series B | 0 |
9/2018 | Endotronix | Series D | 0 |
11/2014 | Quanta | Series B | 43.1M |
2/2022 | Perfuze | Series A | 0 |
7/2021 | Coave Therapeutics | Series B | 0 |
6/2021 | Palliare | Series A | 0 |
6/2021 | Quanta | Series D | 0 |
3/2021 | INNOVO by Atlantic Therapeutics | Venture Round | - |
6/2020 | Shorla Pharma | Series A | 0 |
7/2019 | Quanta | Series C | 0 |
5/2019 | Storm Therapeutics | Series A | 0 |
4/2019 | Fusion Pharmaceuticals | Series B | 0 |
1/2019 | PQ Bypass | Private Equity Round | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2017 | Investment Fund | $107.8M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|